A study on osteosarcoma demonstrated that zeylenone could synergize with cisplatin, enhancing cisplatin efficacy by inducing DNA damage and cell cycle arrest and activating the AKT/GSK3β signaling pathway (Yang et al., 2021). Here, AKT1 is linked to osteosarcoma.